[HTML][HTML] Bioprinting cell-and spheroid-laden protein-engineered hydrogels as tissue-on-chip platforms

DF Duarte Campos, CD Lindsay, JG Roth… - … in Bioengineering and …, 2020 - frontiersin.org
Human tissues, both in health and disease, are exquisitely organized into complex three-
dimensional architectures that inform tissue function. In biomedical research, specifically in …

Microfluidic droplet-assisted fabrication of vessel-supported tumors for preclinical drug discovery

Y Wu, Y Zhao, Y Zhou, K Islam… - ACS Applied Materials & …, 2023 - ACS Publications
High-fidelity in vitro tumor models are important for preclinical drug discovery processes.
Currently, the most commonly used model for in vitro drug testing remains the two …

[HTML][HTML] Immersion bioprinting of tumor organoids in multi-well plates for increasing chemotherapy screening throughput

E Maloney, C Clark, H Sivakumar, KM Yoo, J Aleman… - Micromachines, 2020 - mdpi.com
The current drug development pipeline takes approximately fifteen years and $2.6 billion to
get a new drug to market. Typically, drugs are tested on two-dimensional (2D) cell cultures …

Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment

L Neufeld, E Yeini, N Reisman, Y Shtilerman… - Science …, 2021 - science.org
Many drugs show promising results in laboratory research but eventually fail clinical trials.
We hypothesize that one main reason for this translational gap is that current cancer models …

Microfluidic bioprinting for organ-on-a-chip models

F Yu, D Choudhury - Drug discovery today, 2019 - Elsevier
Highlights•Bioprinting can be used to fabricate organ-on-a-chip models owing to its ability to
print multiple materials and cell types simultaneously with good spatial resolution and …

Bioprinting of in vitro tumor models for personalized cancer treatment: a review

S Mao, Y Pang, T Liu, Y Shao, J He, H Yang… - …, 2020 - iopscience.iop.org
Studying biological characteristics of tumors and evaluating the treatment effects require
appropriate in vitro tumor models. However, the occurrence, progression, and migration of …

Tumor spheroid-on-a-chip: A standardized microfluidic culture platform for investigating tumor angiogenesis

J Ko, J Ahn, S Kim, Y Lee, J Lee, D Park, NL Jeon - Lab on a Chip, 2019 - pubs.rsc.org
The field of microfluidics-based three-dimensional (3D) cell culture system is rapidly
progressing from academic proof-of-concept studies to valid solutions to real-world …

[HTML][HTML] Bioprinting and its use in tumor-on-a-chip technology for cancer drug screening: A review

L Fang, Y Liu, J Qiu, W Wan - International journal of bioprinting, 2022 - ncbi.nlm.nih.gov
The rising global incidence of cancer and high attrition rates of anticancer drugs make it
imperative to design novel screening platforms to increase the success rate of …

Engineering Mesoscopic 3D Tumor Models with a Self‐Organizing Vascularized Matrix

F De Lorenzi, N Hansen, B Theek, R Daware… - Advanced …, 2024 - Wiley Online Library
Advanced in vitro systems such as multicellular spheroids and lab‐on‐a‐chip devices have
been developed, but often fall short in reproducing the tissue scale and self‐organization of …

[HTML][HTML] Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model

N Moghimi, SA Hosseini, AB Dalan… - Scientific Reports, 2023 - nature.com
Cancer treatment resistance is a caused by presence of various types of cells and
heterogeneity within the tumor. Tumor cell–cell and cell-microenvironment interactions play …